Microbix Biosystems Inc.
MBX.TO
TSX
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -32.36% | -14.07% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -32.36% | -14.07% | |||
| Cost of Revenue | -1.04% | -8.20% | |||
| Gross Profit | -53.68% | -17.65% | |||
| SG&A Expenses | -9.95% | 10.81% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -3.21% | -1.07% | |||
| Operating Income | -871.89% | -82.03% | |||
| Income Before Tax | -8,345.14% | -97.65% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -8,345.14% | -97.65% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -8,345.14% | -97.65% | |||
| EBIT | -871.89% | -82.03% | |||
| EBITDA | -251.29% | -55.40% | |||
| EPS Basic | -8,500.00% | -97.78% | |||
| Normalized Basic EPS | -5,400.00% | -96.43% | |||
| EPS Diluted | -8,800.00% | -97.67% | |||
| Normalized Diluted EPS | -5,400.00% | -96.43% | |||
| Average Basic Shares Outstanding | 0.52% | 3.66% | |||
| Average Diluted Shares Outstanding | -0.01% | 3.74% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||